Actavis Inc recalls Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cinci
Recalled February 22, 2017 · FDA recall D-0476-2017 · Actavis
Hazard
Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point. · FDA Class II
Units
499320 units
Sold at
Nationwide in US
Description
Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.
Product
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
Manufacturer(s)
Actavis Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →